Quantifying lead-attributable cardiovascular disease burden in the United States

Area of Science:

• Environmental Health
• Cardiovascular Disease Epidemiology
• Toxicology

Background:

• Lead exposure is a known risk factor for various cardiovascular diseases (CVD).
• Understanding trends in lead exposure-related CVD burden is crucial for public health.
• Previous research indicates a link between lead and adverse cardiovascular outcomes.

Purpose of the Study:

• To quantify the trends in age-standardized CVD mortality and disability-adjusted life years (DALYs) attributed to lead exposure in the United States from 1990 to 2019.
• To assess the impact of reduced lead exposure on cardiovascular health outcomes.
• To provide updated epidemiological data on lead's contribution to CVD burden.

Main Methods:

• Utilized data from the 2019 Global Burden of Disease Study.
• Analyzed age-standardized mortality rates and DALYs related to lead exposure for cardiovascular diseases.
• Calculated percentage changes in CVD mortality and DALYs attributable to lead exposure between 1990 and 2019 in the US.

Main Results:

• A 60% reduction in age-standardized CVD mortality attributable to lead exposure (from 7.4 to 2.9 per 100,000).
• A 66% decrease in age-standardized CVD DALYs attributed to lead exposure (from 143.2 to 48.7 per 100,000).
• Significant decline observed in lead-associated cardiovascular disease burden over three decades.

Conclusions:

• Lead exposure has been substantially reduced as a cause of cardiovascular disease mortality and disability in the US.
• Public health efforts to mitigate lead exposure have likely contributed to these positive trends.
• Continued monitoring and prevention strategies are essential to further reduce lead's impact on cardiovascular health.